Datopotamab deruxtecan for the treatment of unresectable NSCLC after failure of first-line therapy.
Daiichi Sankyo
Posted inNew Drugs, Oncology, Regulatory
Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer
Trastuzumab deruxtecan, developed by AstraZeneca and Daiichi Sankyo, will save lives when Herceptin, Perjeta, and Kadcyla haven’t worked.